================================================================================
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 10-QSB
--------------------
(Mark One)
[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended December 31, 2005.
[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT
For the transition period from N/A to N/A
--------------------
Commission File No. 0-25474
--------------------
MEDCOM USA, INCORPORATED
(Name of small business issuer as specified in its charter)
DELAWARE 65-0287558
State of Incorporation IRS Employer Identification No.
7975 NORTH HAYDEN ROAD, SUITE D-333
SCOTTSDALE, AZ 85258
(Address of principal executive offices)
(480) 675-8865
(Issuer's telephone number)
Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Yes [X] No [_]
The number of shares of the issuer's common equity outstanding as of
February 7, 2006 was 61,306,436 shares of common stock.
Transitional Small Business Disclosure Format (check one):
Yes [_] No [X]
================================================================================
1
MEDCOM USA, INC.
INDEX TO FORM 10-QSB FILING
FOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2005
TABLE OF CONTENTS
PART I
FINANCIAL INFORMATION PAGE
Item 1. Financial Statements
Balance Sheet
As of December 31, 2005. . . . . . . . . . . . . . . 3
Statements of Operations
For the Three and Six Months Ended December 31, 2005
and 2004 . . . . . . . . . . . . . . . . . . . . . . 4
Statements of Cash Flows
For the Six Months Ended December 31, 2005
and 2004 . . . . . . . . . . . . . . . . . . . . . . 5
Notes to the Financial Statements. . . . . . . . . . . . . 6 - 10
Item 2. Management's Discussion and Analysis of Financial Condition and
Results of Operations. . . . . . . . . . . . . . . . . . . 10 - 17
PART II
OTHER INFORMATION
Item 1. Legal Proceedings. . . . . . . . . . . . . . . . . . . . . . . . 17
Item 3. Control and Procedures.. . . . . . . . . . . . . . . . . . . . . 17
Item 6. Exhibits and Reports on Form 8-K
CERTIFICATIONS
Exhibit 31 - Management Certification. . . . . . . . . . . . . . 19
Exhibit 32 - Sarbanes-Oxley Act. . . . . . . . . . . . . . . . . 20
2
PART I - FINANCIAL INFORMATION
ITEM 1 - FINANCIAL STATEMENTS
MEDCOM USA, INC.
BALANCE SHEET (UNAUDITED)
AS OF DECEMBER 31, 2005
ASSETS:
CURRENT ASSETS
Cash $ 40,815
Licensing Contracts - ST 1,262,291
Prepaid expenses and other current assets 182,333
-------------
Total current assets 1,485,440
PROCESSING TERMINALS, net 2,080,942
PROPERTY AND EQUIPMENT, net 259,141
Licensing Contracts - LT 1,723,049
-------------
TOTAL ASSETS $ 5,548,572
=============
LIABILITIES AND STOCKHOLDERS' EQUITY:
CURRENT LIABILITIES:
Accounts payable $ 246,980
Accrued expenses and other liabilities 371,557
Dividend payable 23,750
Notes from Affiliates 702,108
Deferred revenue - current portion 1,252,701
Licensing obligations - current portion 2,919,468
-------------
Total current liabilities 5,516,564
LICENSING OBLIGATIONS - long-term portion 3,184,604
DEFERRED REVENUE 2,517,411
-------------
Total liabilities 11,218,579
-------------
STOCKHOLDERS' EQUITY:
Convertible preferred stock, Series A $.001par value, 52,900 shares
designated, 4,250 issued and outstanding 4
Convertible preferred stock, Series D $.01par value, 50,000 shares
designated, 2,850 issued and outstanding 29
Common stock, $.0001 par value, 80,000,000 shares authorized,
61,306,436 issued and 59,077,105 outstanding 9,409
Treasury stock (37,397)
Paid in capital 77,701,978
Accumulated deficit (83,344,030)
-------------
Total stockholders' equity (5,670,007)
-------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 5,548,572
=============
See the accompanying notes to these unaudited financial statements.
3
MEDCOM USA, INC.
STATEMENT OF OPERATIONS (UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2005 AND 2004
Three Months Ended Six Months Ended
2005 2004 2005 2004
-------------------------- --------------------------
REVENUES:
Terminal sales $ 36,834 $ 203,221 $ 133,438 $ 359,587
Service 914,688 282,600 631,527 715,598
Licensing Fees 1,067,216 292,656 3,362,103 579,059
-------------------------- --------------------------
2,018,738 778,477 4,127,068 1,654,244
COST OF DELIVERABLES: 936,805 35,912 2,305,388 215,762
-------------------------- --------------------------
GROSS PROFIT 1,081,933 742,565 1,821,680 1,438,482
-------------------------- --------------------------
OPERATING EXPENSES:
General and administrative 1,141,769 1,004,492 2,976,747 1,918,873
Sales and marketing 144,902 48,151 286,235 339,344
Professional and consulting fees - 499,508 - 629,908
Royalties - 18,956 - 45,578
Depreciation and amortization 758,824 383,552 1,342,100 745,941
-------------------------- --------------------------
Total operating expenses 2,045,496 1,954,659 4,605,081 3,679,644
-------------------------- --------------------------
OPERATING LOSS (963,563) (1,212,094) (2,783,402) (2,241,162)
-------------------------- --------------------------
OTHER (INCOME) AND EXPENSES
Interest expense 187,484 241,416 265,391 441,518
Interest Income (225,211) (3,027) (274,350) (12,428)
Loss on disposal of assets - - 25,016
-------------------------- --------------------------
Total other expense (37,727) 238,389 (8,960) 454,106
-------------------------- --------------------------
NET LOSS (925,837) (1,450,483) (2,774,442) (2,695,268)
-------------------------- --------------------------
NET LOSS PER SHARE:
Basic: $ (0.02) $ (0.03) $ (0.05) $ (0.05)
========================== ==========================
Diluted: $ (0.02) $ (0.03) $ (0.05) $ (0.05)
========================== ==========================
Weighted Average Common Shares Outstanding
Basic 59,077,105 51,930,710 58,090,470 50,871,598
========================== ==========================
Diluted 59,077,105 51,930,710 58,090,470 50,871,598
========================== ==========================
See the accompanying notes to these unaudited financial statements.
4
MEDCOM USA, INC.
STATEMENT OF CASH FLOWS (UNAUDITED)
FOR THE SIX MONTHS ENDED DECEMBER 31, 2005 AND 2004
2005 2004
------------ ------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) $(2,774,442) $(2,695,268)
Adjustments to reconcile net income to net cash
(used in) operating activities:
Depreciation and amortization 1,342,099 745,941
Issuance of common stock as compensation for services 1,078,505 576,400
Loss on disposal of assets - 25,016
Changes in assets and liabilities:
Licensing and Leasing Contracts (552,005) (205,028)
Inventories - 80,656
Prepaid and other current assets (135,007) 13,861
Other assets - (59,000)
Accounts payable and accrued liabilities (728,195) (131,905)
Deferred revenue (1,043,609) (579,058)
------------ ------------
Net cash (used) in operating activities: (2,812,654) (2,228,385)
------------ ------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property & equipment - (277,452)
Net repayments of advances to affiliate - 1,237,572
------------ ------------
Net cash (used) and provided by investing activities: - 960,120
------------ ------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal repayments on capital leases (595,090) (747,937)
Net repayments of (advances) to Affiliate (32,634)
Proceeds from sale of common stock 1,239,749 1,442,700
Proceeds from licensing and leasing transaction 2,231,237 722,070
------------ ------------
Net cash provided by financing activities 2,843,262 1,416,833
------------ ------------
INCREASE (DECREASE) IN CASH 30,608 148,568
CASH, BEGINNING OF PERIOD 10,207 86,621
------------ ------------
CASH, END OF PERIOD $ 40,815 $ 235,189
============ ============
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid $ 139,378 $ 212,582
============ ============
Income taxes paid - -
============ ============
SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Terminals capitalized under sales/leaseback transactions $ - $ 765,745
============ ============
Terminals returned and placed back into inventory at net
capitalized cost $ - $ 318,602
============ ============
See the accompanying notes to these unaudited financial statements
5
MEDCOM USA, INC.
NOTES TO FINANCIAL STATEMENTS PERIODS ENDED DECEMBER 31, 2005 AND 2004
1. BASIS OF PRESENTATION
The accompanying unaudited financial statements represent the financial position
of MedCom USA, Inc. ("Company") as of December 31, 2005 and includes results of
operations of the Company for the three and six months ended December 31, 2005
and 2004 and cash flows for the three and six months ended December 31, 2005 and
2004. These statements have been prepared in accordance with generally accepted
accounting principles for interim financial information and the instructions for
Form 10-QSB. Accordingly, they do not include all the information and footnotes
required by generally accepted accounting principles ("GAAP") for complete
financial statements. In the opinion of management, all adjustments to these
unaudited financial statements necessary for a fair presentation of the results
for the interim period presented have been made. The results for the three and
six months ended December 31, 2005 and 2004 may not necessarily be indicative of
the results for the entire fiscal year. These financial statements should be
read in conjunction with the Company's Form 10-KSB for the fiscal year ended
June 30, 2005, including specifically the financial statements and notes to such
financial statements contained therein.
Accounting Policies and Estimates
---------------------------------
The preparation of our financial statements in conformity with accounting
principles generally accepted in the United States of America requires our
management to make certain estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting period. As such, in accordance with
the use of accounting principles generally accepted in the United States of
America, our actual realized results may differ from management's initial
estimates as reported. A summary of significant accounting policies are detailed
in notes to the financial statements which are an integral component of this
filing.
Cash and Cash Equivalents
-------------------------
Cash and cash equivalents include all short-term liquid investments that are
readily convertible to known amounts of cash and have original maturities of
three months or less. At times cash deposits may exceed government insured
limits.
Concentration of Credit Risk
----------------------------
The Company maintains its operating cash balances in banks in Islandia, New
York, and in Scottsdale, Arizona. The Federal Depository Insurance Corporation
(FDIC) insures accounts at each institution up to $100,000. The Company has
entered into agreements with Tesia-PCI. The agreements entered into by and
between the Company and Tesia-PCI represents of a major customer of the Company.
The Company realized $1,156,000 from Tesia-PCI during the period presented.
Inventories
-----------
For the period ending December 31, 2004, inventories were carried at the lower
of cost or market on a first-in first-out basis. The Company purchases hardware
from its supplier and records inventory at its original cost. Inventory
terminals are at times returned by customers, and if these units have been sold
and repurchased , the Company recorded the returned inventory units at the
amortized capitalized cost under the sale-leaseback arrangements. The
capitalized costs under the sale-leaseback transactions are substantially
greater than the
6
original purchase price from the supplier. Due to technological changes terminal
are no longer considered an integral component in the generation of revenue.
Accordingly effective July 1, 2005 terminals are expensed rather than
capitalized as inventory terminals that have a nominal individual value. For the
period ending July 1, 2005 the Company adopted a new method of accounting and no
longer carries inventory as its method of accounting. "See Revenue Recognition"
Property and Equipment
----------------------
Property and equipment is stated at cost less accumulated depreciation.
Depreciation is recorded on a straight-line basis over the estimated useful
lives of the assets ranging from 3 to 5 years. The Company's leaseback
transactions of processing terminals to healthcare providers are generally for a
period of 48 to 60 months. Depreciation expense for the leased terminal assets
are on the straight-line method over the term of the lease in amounts necessary
to reduce the carrying amount of the terminal asset. Estimated and actual
residual values are reviewed on a regular basis to determine that depreciation
amounts are appropriate.
Property & Equipment 865,651
Accumulated Depreciation (606,510)
---------
Net Property & Equipment 259,141
Assets Held under Capital Leases
--------------------------------
Assets held under capital leases are recorded at the lower of the net present
value of the minimum lease payments or the fair value of the leased asset at the
inception of the lease. Amortization expense is computed using the straight-line
method over the shorter of the estimated useful lives of the assets or the
period of the related lease. Effective July 1, 2005, the Company has adopted a
new method of accounting and will discontinue the capitalization of terminal
Assets. (See "Revenue Recognition")
Amortization of Leasehold Improvements
--------------------------------------
Amortization of leasehold improvements is computed using the straight-line
method over the shorter of the remaining lease term or the estimated useful
lives of the improvements. All leasehold improvements have been fully amortized
as of December 31, 2005.
Revenue Recognition
-------------------
The Company recognized income on monthly service and transaction fees it charges
to customers in the month in which the service is provided. Income on
sale-leaseback transactions, prior to July 1, 2005, is deferred and recognized
over the term of the leaseback. Management has determined that the
sale-leaseback transactions are capital leases.
The terminals were capitalized at the value determined by the lessor on the
basis of the cash flow under the terms of the sale and service agreements with
the customers are as follows.
Terminal Assets 6,197,320
Accumulated Amortization (4,116,378)
-----------
Net Terminal Assets 2,080,942
The Company has since upgraded its technology to address its core revenue model
that is the sale of medical software. In recognition of the changes in
technology and certain modifications to its licensing agreements the Company has
adopted a new accounting method effective July 1, 2005, in accordance with SOP
97-2 and EITF
7
00-21, which they believe better matches revenue and expenses. SOP 97-2 applies
to all entities that license, sell, lease, or market computer software. It also
applies to "hosting" arrangements in which the customer has the option to take
possession of the software. Hosting arrangements occur when end users do not
take possession of the software but rather the software resides on the vendor's
or a third party's hardware, and the customer accesses and uses the software on
an as-needed basis over the Internet or some other connection. It does not,
however, apply to revenue earned on products containing software incidental to
the product as a whole or to hosting arrangements that do not give the customer
the option of taking possession of the software.
SOP 97-2 provides that revenue should be recognized in accordance with contract
accounting when the arrangement requires significant production, modification,
or customization of the software. When the arrangement does not entail such
requirements, revenue should be recognized when persuasive evidence of an
agreement exists, delivery has occurred, the vendor's price is fixed or
determinable, and collectibility is probable.
The largest part of revenues stems from vendors' license fees associated with
software. The Company has recognized revenue from license fees when the software
was shipped to the customer. The amount and timing of revenue recognition is
complicated, however, by multiple-element arrangements that provide for multiple
software deliverables [e.g., software products, upgrades or enhancements,
postcontract customer support (PCS), or other services]. In hosting arrangements
that are within the scope of SOP 97-2, multiple elements might include specified
or unspecified upgrade rights, in addition to the software product and the
hosting service. The software provider often charges a single fee that must be
allocated to the products delivered in the present and in the future.
In an arrangement with multiple deliverables, EITF 00-21 requires that the
delivered items be considered a separate unit of accounting if the delivered
items have value to the customer on a stand-alone basis, if there is objective
and reliable evidence of the fair value of the undelivered items, and if the
arrangement includes a general right of return for the delivered item, or if
delivery or performance of the undelivered items is considered probable and
substantially in the control of the vendor. EITF 00-21 requires allocation of
the vendor's fee to the various elements based on each element's stand-alone
value.
In general, both SOP 97-2 and EITF 00-21 require allocating revenue to all of
the elements of a multiple-deliverable arrangement using the relative fair value
method, where objective and reliable evidence of fair value is present for all
the products contained in the group.
Management has established Vendor-Specific Objective Evidence ("VSOE") for
access fee, equipment, provider enrollment fee, EDI connectivity fee,
Payer/Provider fee, benefit verification fee, referral transfer fee, service
authorization fee, claim status, training, support, program upgrades, carrier
editions, and customized reports. Revenue is accordingly allocated and
recognized based on the value of deliverables. VSOE relates the method of
accounting under SOP 97-2 and EITF 00-21.
Income Taxes
------------
Management evaluates the probability of the utilization of the deferred income
tax assets. The Company has estimated a $23,652,000 deferred income tax asset at
December 31, 2005. Of that amount, $21,206,836 related to net operating loss
carry-forwards at December 31, 2005. Management determined that because the
Company has not yet generated taxable income it was not appropriate to recognize
a deferred income tax asset related to the net operating loss carry-forward.
Therefore, a fully deferred income tax asset is offset by an equal valuation
allowance.
8
If the Company begins to generate taxable income, management may determine that
all of the deferred income tax asset may be recognized. Recognition of the asset
could increase after tax income in the future. Federal Net operating loss
carryforwards of $51,189,000 expire from 2011 to 2023. State net operating loss
carryforwards of $29,603,000 expire from 2005 to 2008. During the year ended
June 30, 2005, the Company reduced the state portion of the deferred income tax
asset related to net operating loss carryforwards by $3,484,000 resulting from
the expiration of such carryforwards. The future utilization of the net
operating losses is uncertain. The valuation allowance on the deferred income
tax asset was decreased by $1,648,702 in the year ended June 30, 2005, resulting
primarily to the expiration of state net operating loss carryforwards.
Fair Value of Financial Instruments
-----------------------------------
Financial instruments consist primarily of accounts receivable, and obligations
under accounts payable, accrued expenses, capital lease obligations and notes
payable. The carrying amounts of accounts receivable, accounts payable, accrued
expenses and notes payable approximate fair value because of the short maturity
of those instruments. The carrying value of the Company's capital lease
arrangements approximates fair value because the instruments were valued at the
cost of the equipment at the time the Company entered into the arrangements. The
Company has applied certain assumptions in estimating these fair values. The use
of different assumptions or methodologies may have a material effect on the
estimates of fair values.
Net Loss Per Share
------------------
Net loss per share is calculated using the weighted average number of shares of
common stock outstanding during the year. The Company has adopted the provisions
of Statement of Financial Accounting Standards No. 128, Earnings Per Share.
Use of Estimates
----------------
The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions.
This may affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements, and
the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.
Stock-Based Compensation
------------------------
Statements of Financial Accounting Standards No. 123, Accounting for Stock-Based
Compensation, ("SFAS 123") established accounting and disclosure requirements
using a fair-value based method of accounting for stock-based employee
compensation. In accordance with SFAS 123, the Company has elected to continue
accounting for stock based compensation using the intrinsic value method
prescribed by Accounting Principles Board Opinion No. 25, "Accounting for Stock
Issued to Employees."
Intangible Assets
-----------------
During the period of quarter ended 2004, goodwill was recognized in the
Company's acquisition of MedCom. Since that time, the Company has divested of
all other business segments. Management had impaired the assets in total since
there was not sufficient evidence that the Company will generate operating
income and operating cash flows. The technology of the company has changed that
the asset no longer has value.
9
Impairment of Assets
--------------------
The Company performs an assessment of impairment of long-lived assets
periodically whenever there is an indication that the carrying amount of the
asset may not be recoverable. Recoverability of these assets is determined by
comparing the forecasted undiscounted cash flows generated by those assets to
the assets' net carrying value. The amount of impairment loss, if any, is
measured as the difference between the net book value of the assets and the
estimated fair value of the related assets.
2. Common Stock Transactions
During the quarter ended December 31, 2005, the Company issued 950,000 shares of
common stock for net cash proceeds of $380,000. Additionally, the Company
granted 811,500 common shares as consideration for services and compensation.
There were no options granted in the end of the period of December 31, 2005 and
all options previously granted have been fully vested and therefore there is no
pro forma effects for the year ended Common stock warrants issued in the quarter
ended December 31, 2005 consist of the following:
Number Exercise Expiration
of Price of
Warrants --------- Warrants
--------- ----------
628,991 $ 4.00 6/30/2006
678,400 $ 1.00 6/30/2007
390,400 $ 2.75 6/30/2007
94,400 $ 3.00 6/30/2008
148,999 $ 4.00 7/30/2008
20,000 $ 4.50 9/30/2008
---------
1,961,190
=========
ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
This portion of this Quarterly Report on Form 10-QSB, includes statements that
constitute "forward-looking statements." These forward-looking statements are
often characterized by the terms "may," "believes," "projects," "expects," or
"anticipates," and do not reflect historical facts. Specific forward-looking
statements contained in this portion of the Quarterly Report include, but are
not limited to our ability to manage growth, involvement in litigation,
competition in the health electronic transaction processing, ongoing contractual
relationships, dependence upon key personnel, changes in customer demand for
product and services, and the adoption of new, or changes in, accounting
policies, practices and estimates and the application of such policies,
practices, and estimates, and federal and state governmental regulation,
specifically in the areas of electronic transaction processing in the health
care industries.
Forward-looking statements involve risks, uncertainties and other factors, which
may cause our actual results, performance or achievements to be materially
different from those expressed or implied by such forward-looking statements.
Factors and risks that could affect our results and achievements and cause them
to materially differ from those contained in the forward-looking statements
include those identified in the section titled "Risk Factors" in the Company's
Annual Report on Form 10-KSB for the year ended June 30, 2005, as well as other
factors that we are currently unable to identify or quantify, but that may exist
in the future.
10
In addition, the foregoing factors may affect generally our business, results of
operations and financial position. Forward-looking statements speak only as of
the date the statement was made. We do not undertake and specifically decline
any obligation to update any forward-looking statements.
OVERVIEW
MedCom USA, Inc. (the "Company") a Delaware corporation was formed in August
1991 under the name Sims Communications, Inc. The Company's primary business was
providing telecommunications services. In 1996 the Company introduced four
programs to broaden the Company's product and service mix: (a) cellular
telephone activation, (b) sale of prepaid calling cards, (c) sale of long
distance telephone service and (d) rental of cellular telephones using an
overnight courier service. With the exception of the sale of prepaid calling
cards, these four programs were discontinued in December 1997. During the fiscal
year of 1998, the Company diversified its operations and moved into the area of
medical information processing.
The Company changed its name to MedCom USA, Inc. in October 1999. During the
fiscal years of 1999 and continuing through 2000, the Company directed its
efforts in medical information processing. As of December 31, 2005, the Company
currently operates the MedCom System (MedCom) that is deployed through a
point-of-sale terminal or personal computer offering electronic transaction
processing, as well as insurance eligibility verification. The Company has
aggressively focused on its primary operations in Electronic Data Interchange
(EDI) and core business in electronic Medical Transaction Processing.
MEDICAL TRANSACTION PROCESSING
------------------------------
MEDCOM SYSTEM
The Company provides innovative technology-based solutions for the healthcare
industries that enable users to efficiently collect, use, analyze and
disseminate data from payers, health care providers and patients. The MedCom
System currently operates through a point-of-sale terminal or a personal
computer. The point-of-sale terminals are purchased from Hypercom Corporation
(Hypercom). The MedCom System also operates a PC version and an on-line version.
The Company is in the process of assessing the feasibility of offering a service
bundled package that would have the capability of processing unlimited claims
and eligibility verification for monthly service fees.
The Company has developed a "portal" system that encourages customers to process
their medical claims through an online portal. Many customers purchase the
terminal for the front office and the portal system for the back office to take
advantage of the ease of both products.
FINANCIAL SERVICES
The Company's credit card center and check services, provides the healthcare
industry a combination of services designed to improve collection and approvals
of credit/debit card payments along with the added benefit and convenience of
personal check guarantee from financial institutions.
Flex-pay is an accounts receivable management program that allows a provider to
swipe a patient's credit card and store the patient's signature in the
terminals, and bill the patient's card at a later date when it is determined
what services rendered were not covered by the patient's insurance. Also, an
easy-pay option is offered which allows patient's the added benefit and
convenience of a one-time payment option or a recurring installment payments
that will be processed on a specified date determined by the provider and
patient. These options insure providers that payments are timely processed with
the features of electronic accounts receivable management. These services are
all deployed thorough point-of-sale terminals or a personal computer. Using
11
the MedCom system, medical providers are relieved of many of the problems
associated with billings and account management, and results in lower
administrative documentation and costs.
PATIENT ELIGIBILITY
The MedCom System is also an electronic processing system that consolidates
insurance eligibility verification, processes medical claims, and monitors
referrals. The MedCom System allows a patient's primary care physician to
request approval from the patient's insurance carrier or managed care plan for a
referral to a secondary physician or specialist. The secondary physician or
specialist can use the MedCom system to verify referrals are approved by the
patient's insurance carrier. The MedCom system's referral capabilities reduce
documentation and administrative costs which results in increased productivity
and greater patient information for the specialist, as well as a written record
of the referral authorization.
The MedCom System can record and track encounters between patients and health
care providers for performance evaluation and maintenance of records. After
examining a patient the physician enters a patient's name, procedure code and
diagnostic code at a nearby terminal. This information is then uploaded to
MedCom's computer network, processed and transmitted back to the provider
formatted in both summary and/or detailed reports, and as a result healthcare
providers' reimbursements are accelerated and account receivables are reduced.
The average time it takes the healthcare providers to collect payments from
insurance carriers and plans decreases from an average of 89 days to 7-21 days.
Health care providers will benefit from a 100% paperless claim processing
system.
As of June 30, 2005 the MedCom system was able to retrieve on-line eligibility
and authorization information from approximately 450 medical insurance companies
and plans. Included in this group is the newly activated Medicare Part A & B
eligibility for all 50 states. This gives us access to over 42 million lives.
The system also electronically processes and submits claims for its healthcare
providers to over 1,700 companies. These insurance providers include CIGNA,
Prudential, Oxford Health Plan, United Health Plans, Blue Cross, Medicaid,
Aetna, Blue Cross/Blue Shield, and Prudential.
PATENT
The Company has the ability to market and sell licensing opportunities for the
MedCom proprietary patented technology for Activating Phone card and Gift Card
at retail. The patent covers the technology and process for taking a card with
magnetic strip or other data capture mechanism and activating the card by
downloading a determined monetary value onto the card for use at a later date
for different types of transactions. This process can be utilized for prepaid
phone cards, gift cards, and affinity cards. New View Technologies, which was
acquired by MedCom USA, developed the patent and all patents were assigned.
COMPETITION
Competing health insurance claims processing and/or benefit verification systems
include WebMD (HLTH), NDCHealth (NDC), and Per-se Technologies (PSTI). There are
similar companies that compete with the Company with respect to its financial
transaction processing services performed by the MedCom system. These companies
compete with the Company directly or to some degree. Many of these competitors
are better capitalized than the Company, and maintain a significant market share
in their respective industries.
TECHNICAL SUPPORT ASSISTANCE
12
The Company offers multiple training options for its products and services and
is easily accessed at www.MedComUSA.com. The online E-learning tools enable
-----------------
health care professionals and health providers an opportunity to familiarize
themselves with the Health Insurance Portability and Accountability Act (HIPAA)
and also the mandates and compliance issues. Onsite training and
teleconferencing, and technical support assistance are also features offered to
health care providers. Also, a 24-hour terminal replacement program and system
upgrades are offered.
MARKETING STRATEGY
MedCom's marketing plan is built around a strategy of expanding its sales
capacity by using experienced external Independent Sales Organizations (ISO) and
putting less reliance on an internal sales force. MedCom has set-up these
Independent Sales Organizations (ISOs) to market and distribute the MedCom
System throughout the U.S. In addition to regional ISOs which represent
approximately 100+ sales people, the Company has signed an agreement with Abanoc
International and is in the midst of training 200+ sales people in 15 cities
around the country. Initial sales have already begun to result from this
relationship. Financial service companies comprise an important sales channel
that views the healthcare industry as an important growth opportunity. Only 6%
of all healthcare payments are made with a credit card today, although according
to a recent survey 55% of all consumers would prefer to pay doctor and hospital
visits by credit/debit card.
MedCom has been expanding its position with Hospitals. Working closely with
Hospital consultants and targeted seminars. The Company, with its new Online
portal product and Medicare access, is becoming an increasingly valuable tool
for the outpatient and faculty practice areas of hospitals. While the ISO groups
focus on individual doctors, dentists and clinics, our hospital team is focusing
on multiple unit sales opportunities with hospitals around the country.
SERVICE AGREEMENTS
During December 1998, the Company entered into a service agreement with WebMD
Envoy. This agreement encompasses the process of Electronic Data Interchange
(EDI) and related services. The services provided are complimentary to the
Company's core business, and accomplishes transaction processing services that
allows healthcare providers and payers to process medical transactions quickly
and accurately, and results in reduced administrative costs and an increase in
healthcare reimbursements to healthcare providers.
During January 2002, the Company has entered into a service agreement with
MedUnite. This alliance will encompass the utilization of proprietary
technologies and will enhance the existing network of healthcare constituents.
Strategically both companies share the same vision of transforming the
healthcare transactions systems affecting how healthcare providers, health
plans, and other groups transacting business with one another by significantly
reducing claim and payment processing time, and reducing healthcare
administrative costs.
During February 2004, the Company entered into a service agreement with CDS
Capital. This agreement will enable eligible healthcare providers utilizing the
MedCom terminals to finance their accounts receivables. Health care providers
using the MedCom terminal to secure patient eligibility and process claims will
now be able to receive regular payments for a large percentage of claims
processed from the previous week. This financial management service will
decrease the time and costs associated with accounts receivable collections.
During June 2005, the Company entered into a service agreement with Tesia-PCI.
This agreement to replace and service and support at a minimum of 1,500 POS
terminals inclusive of eligibly, claims processing, credit card processing for
Tesia's dental providers.
13
PROCESSING TERMINAL LEASING AGREEMENTS
The Company has entered into leasing agreements for the purpose of leasing
contracts. The Company has pledged and granted for collateral in connection with
the lease agreements one million restricted common shares. These common shares
would be surrendered upon default of the leasing agreements. This pledge and
granting of security interest was executed on January 2002.
The Company arranged its terms with this credit facility as an equipment lessor
whereby the Company sold terminals to the lessor when it has obtained a service
contract with a provider. Under these agreements, the Company leased back the
processing terminals from the lessor and in turn leased them to the purchaser
for a period of 48 to 60 months however; the customer could terminate the
agreement after 12 months. The Company accounted for the transactions as
sale-leasebacks. The leases with the customers are inclusive with the monthly
service contracts and are effectively accounted for as operating leases. Gains
on terminal sales under sale-leaseback transactions are deferred and are being
amortized to income in proportion to amortization of the assets, generally over
the term of the lease with the credit facility generally for a period of 48 to
60 months.
REVENUES
For the six months period ending December 31, 2005 and 2004 the Company licensed
1933 and 754 units respectively. During the prior periods very few customers
terminated there agreements prior to the expiration of the underlying lease.
Additionally, Effective July 1, 2005 the Company modified the licensing
agreement to make them noncancellable for the term of the underlying licensing
agreement. Accordingly, management believes that application of more
appropriately the matching of revenues and cost of licenses entered into after
July 1, 2005.
Revenues from the MedCom system are generated through the sale of terminals, and
processing insurance eligibility/verification, insurance claims, and financial
transaction processing. The Company receives a fixed amount per terminal, and
also receives fees for each transaction processed through the MedCom System.
Revenue sources include fees for financial transactions processed through the
terminal, fees for collection of receivables if the Company provides billing
services, fees associated with reimbursements made by insurance carriers for
submitting claims that are processed electronically, fees for using the system's
referral program and, fees for processing uploaded data. The Company also
markets a complete billing service using the MedCom System for hospitals and
large practice groups. The Company receives a percentage of the billing amount
collected under these arrangements.
Due to changes in technology and certain modification to the licenses
agreements, the Company has adopted a new method of accounting and revenue
recognition in accordance with SOP 97-2 and EITF 00-21 (See "Revenue
Recognition")
ADDITIONAL INFORMATION
MedCom files reports and other materials with the Securities and Exchange
Commission. These documents may be inspected and copied at the Commission's
Public Reference Room at 450 Fifth Street, N.W., Washington, D.C., 20549. You
can obtain information on the operation of the Public Reference Room by calling
the Commission at 1-800-SEC-0330. You can also get copies of documents that the
Company files with the Commission through the Commission's Internet site at
www.sec.gov.
-----------
RESULTS OF OPERATIONS
14
Revenues for the quarter ended December 31, 2005 increased to $2,018,738 as
compared to the quarter ended December 31, 2004 of $778,477. This increase in
revenue is directly the result of changes in the Company's strategic direction
in core operations. The Company continues to aggressively pursue and devote its
resources and focus its direction in electronic transaction processing. The
increase in income relates to the implementation of the change in accounting
method as discussed above and a direct increase in the number of units and
portals licensed. The prior accounting method was in accordance of SAFS 13
implementation of the sale lease back method. The company adopted an accounting
method in accordance with SOP 97-2 and EITF 00-21 which applies to entities that
sell computer software.
Cost of deliverables for the quarter ended December 31, 2005 increased to
$936,805 as compared to quarter ended December 31, 2004 of $35,912. Increase in
the volume of sales has directly increased the volume of transaction processing
and as a result has increased the total costs of processing transactions. The
company adopted a method of accounting that provided a better matching of income
and expenses and is in accordance to SOP 97-2 and EITF 00-21. In the past, the
company generated revenues through licenses utilized the use of the medical
terminal and related software. However while the development of proprietary
software, the software can be utilized through a portal system which rendered
the medical terminals sales no longer the core revenue model for the Company.
General and administrative expenses for quarter ended December 31, 2005
increased to $1,141,769 as compared to quarter ended December 31, 2004 of
$1,004,492. This increase is attributed to the Company's hiring of additional
employees as growth has occurred in the area of providing technical support for
our products and services in relation to increases in sales. The Company issued
stock for services in the amount of $324,000 which increased the overall General
and Administrative expenses. The services rendered for the stock included
software development, royalties expenses, and consulting services by vendors.
Vendors that will accept stock for services reduces the burden of cash flow
maintained. The Company also combined professional fees with general and
administrative expenses to better report financial position.
Selling expenses for the quarter ended December 31, 2005 increased to $144,902
as compared to quarter ended December 31, 2004 of $48,151. This increase is
primarily the result of the increase in marketing efforts and includes
commissions paid to external sales personnel to market the Company's products
and services. The Company has begun a campaign to increase internal sales force
in 15 separate states to maintain the integrity of the product proprietary
technology. The Company's increases in General and Administrative costs reflect
this new corporate campaign.
Interest expense for the quarter ended December 31, 2005 decreased to $187,484
as compared to December 31, 2004 of $241,416. This decrease is a result of
payments made and interest income recognized from the note receivable made to
the affiliate. Further the Company has been accelerating payments to Ladco one
of its financing arrangements. The payments to Ladco represent a high interest
rate and it has been a Company initiative to reduce the Ladco debt.
Interest Income for the quarter ended December 31, 2005 increased to $225,211 as
compared to December 31, 2004 of $3,027. The increase in interest income is a
result of the implementation of the new accounting method that better considers
interest earned on the licensing contracts in accordance with SOP 97-2 and EITF
00-21.
Depreciation and Amortization for the quarter ended December 31, 2005 increased
to $758,824 as compared to December 31, 2004 of $383,552. This increase is a
result of accelerated depreciation of terminal assets. The accelerated
retirement of those assets is a result of the change in accounting method that
better reflects the change in company revenue generation model.
15
No tax benefit was recorded on the expected operating loss for the quarter ended
December 31, 2005 as required by Statement of Financial Accounting Standards No.
109, Accounting for Income Taxes. For the quarter ended we do not expect to
realize a deferred tax asset and it is uncertain, therefore we have provided a
100% valuation of the tax benefit and assets until we are certain to experience
net profits in the future to fully realize the tax benefit and tax assets.
Net loss for the quarter ended December 31, 2005 was ($925,837) compared net
loss for the quarter ended December 31, 2004 of ($1,450,483).
LIQUIDITY AND CAPITAL RESOURCES
Cash used in operating activities for the six months ended December 31, 2005,
was ($2,812,654) as compared to cash used in operating activities for the six
months ended December 31, 2004 of ($2,228,385). Overall sales have increased in
the areas of direct sales along with sales-leaseback transactions. The increase
in cash used in operating activities was a result in the change in accounting
method to better match income and expenses and further related to the decrease
in accounts payables and decrease in deferred revenue.
Cash used for investing activities for the six months ended December 31, 2004
was $960,120. There has been terminal equipment that has been transacted as
sales-leaseback transactions and terminal software upgrade expenses that have
been incurred.
Cash provided by financing activities was $2,843,262 for the six months ended
December 31, 2005 compared to cash provided by financing activities for the six
months ended December 31, 2004 of $1,416,833. The Company has increased the
amount of transacted sales in connection with its terminal equipment though
direct sales, and as a result has decreased sales and the related financing
through its credit facility. The Company increased proceeds from capital leases
by $2,231,237, collected $1,259,749 in proceeds from the sale of common stock
and repaid capital leases facilities by $595,090. The Company repaid its
affiliate $32,634.
SOURCES OF CAPITAL
The Company has secured an arrangement with a third party leasing company to
provide funds upon the execution of a rental and service agreement with a
customer. Generally, the health care provider customer will enters into an
agreement with the Company to lease a terminal licensing software and subscribe
to the transaction processing and insurance verification service. At that time,
the Company sells the terminal and licensing rights associated with the service
contract to the lessor and lease back that terminal. The leasing transactions
provide for funding to the Company to cover its cost of the terminal and
software, placement of the terminal with the customer and a profit margin. The
Company is generally required to pay the lease rentals to the lessor from 48 to
60 months. The source of funds for the repayments is the payments from the
health care provider customer. The Sources of Capital come from Ladco and Leeco
who are our main provider of financing for the Company.
OTHER CONSIDERATIONS
There are numerous factors that affect our business and the results of its
operations. Sources of these factors include general economic and business
conditions, federal and state regulation of business activities, the level of
demand for the Company's product or services, the level and intensity of
competition in the medical transaction processing industry and the pricing
pressures that may result, the Company's ability to develop new services based
on new or evolving technology and the market's acceptance of those new services,
the Company's ability to timely and effectively manage periodic product
transitions, the services, customer and geographic sales mix
16
of any particular period, and the ability to continue to improve infrastructure
including personnel and systems, to keep pace with the growth in its overall
business activities.
FORWARD-LOOKING STATEMENTS
Except for historical information contained herein, this Form 10-QSB contains
express or implied forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933 and Section 21E of the Exchange Act. The Company
intends that such forward-looking statements be subject to the safe harbors
created thereby. The Company may make written or oral forward-looking statements
from time to time in filings with the SEC, in press releases, or otherwise. The
words "believes," "expects," "anticipates," "intends," "forecasts," "project,"
"plans," "estimates" and similar expressions identify forward-looking
statements. Such statements reflect the current views with respect to future
events and financial performance or operations and are only as of the date the
statements are made. Forward-looking statements involve risks and uncertainties
and readers are cautioned not to place undue reliance on forward-looking
statements. The Company's actual results may differ materially from such
statements. Factors that cause or contribute to such differences include, but
are not limited to, those discussed elsewhere in this Form 10-QSB, as well as
those discussed in Form 10-KSB which is incorporated by reference in this Form
10-QSB.
Management believes that the assumptions underlying the forward-looking
statements are reasonable, any of the assumptions could prove inaccurate and,
therefore, there can be no assurance that the results contemplated in such
forward-looking statements will be realized. The inclusion of such
forward-looking information should not be regarded, as a representation that the
future events, plans, or expectations contemplated will be achieved. The Company
undertakes no obligation to publicly update, review, or revise any
forward-looking statements to reflect any change in expectations or any change
in events, conditions, or circumstances on which any such statements are based.
Our filings with the Securities Exchange Commission, including the Form 10-KSB,
and may be accessed at the SEC's web site, www.sec.gov.
------------
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
MedCom is involved in various legal proceedings and claims as described in
our Form 10-KSB for the year ended June 30, 2005. No material developments
occurred in any of these proceedings during the quarter ended December 31, 2005.
The costs and results associated with these legal proceedings could be
significant and could affect the results of future operations.
ITEM 3. CONTROLS AND PROCEDURES
EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
Disclosure controls and procedures are designed with an objective of ensuring
that information required to be disclosed in our periodic reports filed with the
Securities and Exchange Commission, such as this Quarterly Report on Form
10-QSB, is recorded, processed, summarized and reported within the time periods
specified by the Securities and Exchange Commission. Disclosure controls are
also designed with an objective of ensuring that such information is accumulated
and communicated to our management, including our chief executive officer, in
order to allow timely consideration regarding required disclosures.
The evaluation of our disclosure controls by our principal executive officer
included a review of the controls' objectives and design, the operation of the
controls, and the effect of the controls on the information presented in this
Quarterly Report. Our management, including our chief executive officer, does
not expect that disclosure
17
controls can or will prevent or detect all errors and all fraud, if any. A
control system, no matter how well designed and operated, can provide only
reasonable, not absolute, assurance that the objectives of the control system
are met. Also, projections of any evaluation of the disclosure controls and
procedures to future periods are subject to the risk that the disclosure
controls and procedures may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may
deteriorate.
Based on their review and evaluation as of the end of the period covered by this
Form 10-QSB, and subject to the inherent limitations all as described above, our
principal executive officer have concluded that our disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934) are effective as of the end of the period covered by this
report. They are not aware of any significant changes in our disclosure controls
or in other factors that could significantly affect these controls subsequent to
the date of their evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses. During the period covered by
this Form 10-QSB, there has been changes in our internal control over financial
reporting that have materially affected, or that are reasonably likely to
materially affect, our internal control over financial reporting.
In prior periods, the company had reportable internal control deficiencies in
the recording and proper counting of terminal units which had a cost of $394 per
unit. The company became aware of this reportable deficiency and immediately
took steps to overcome this control deficiency. The Company hired an accounting
consultant to assess the accounting method and the company changed is accounting
method to the preferred method. The company no longer relies on the inventory as
a method of accounting under FAS 13. The changes in accounting method allows the
company to report revenue based on the licensing and lease agreements and not on
a per terminal sale.
ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K
REPORTS ON FORM 8-K
Changes in Registrant's Certifying Accountant.
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, there unto duly authorized.
18